Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

TL 350

Known as: 1H-Indol-6-ol, 4-(2-(dipropylamino)ethyl)-, TL-350 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Gluconeogenesis is a major source of hyperglycemia in patients with type 2 diabetes mellitus (T2DM), thus targeting… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
1984
1984
Intravenous and intraduodenal injection of a new ergoline derivative, TL-350, produced dose-dependent inhibition of heart rate… Expand